EB
RPRX icon

Eastern Bank’s Royalty Pharma RPRX Stock Holding History

Eastern Bank’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$41.4M Buy
708,768
+13,843
+2% +$817K 0.63% 45
2026
Q2 		$39M Buy
694,925
+35,547
+5% +$1.85M 0.6% 48
2026
Q1 		$31.6M Buy
659,378
+24,256
+4% +$1.06M 0.54% 50
2025
Q4 		$24.5M Buy
635,122
+263,867
+71% +$10.1M 0.42% 56
2025
Q3 		$13.1M Buy
371,255
+345,968
+1,368% +$12.5M 0.23% 79
2025
Q2 		$911K Sell
25,287
-1,157
-4% -$38.3K 0.02% 196
2025
Q1 		$823K Sell
26,444
-28,871
-52% -$915K 0.02% 219
2024
Q4 		$1.41M Sell
55,315
-659
-1% -$17.5K 0.03% 187
2024
Q3 		$1.58M Sell
55,974
-514
-0.9% -$14.2K 0.03% 194
2024
Q2 		$1.49M Sell
56,488
-414
-0.7% -$11.5K 0.06% 123
2024
Q1 		$1.73M Sell
56,902
-8,765
-13% -$258K 0.07% 120
2023
Q4 		$1.84M Sell
65,667
-11,316
-15% -$311K 0.08% 118
2023
Q3 		$2.09M Sell
76,983
-243,177
-76% -$7.22M 0.1% 114
2023
Q2 		$9.84M Buy
320,160
+623
+0.2% +$21.1K 0.47% 72
2023
Q1 		$11.5M Buy
319,537
+86,238
+37% +$3.2M 0.58% 69
2022
Q4 		$9.22M Buy
+233,299
New +$9.74M 0.49% 66

Other funds holding RPRX

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
KA
Kearns & Associates Palos Verdes Estates, California $218M AUM 16.36% 1-Year Est. Return
MGI
Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 31.62% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Eastern Bank's RPRX Position: Q3 2026 in Review

Eastern Bank increased its Royalty Pharma (RPRX) stake by 2% in Q3 2026, buying an estimated $817K and bringing the position to 708,768 shares worth $41.4M. The position accounts for 0.63% of the portfolio, ranked #45.

Eastern Bank first reported a position in RPRX in Q4 2022 and has held it in 16 quarters since. 21 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Eastern Bank held 708,768 shares of Royalty Pharma worth $41.4M as of Q3 2026.
  • Eastern Bank bought 13,843 Royalty Pharma shares in Q3 2026, an estimated $817K.
  • Royalty Pharma made up 0.63% of Eastern Bank's portfolio in Q3 2026, its #45 holding.
  • Eastern Bank first reported a position in Royalty Pharma in Q4 2022 and has held it in 16 quarters since.
  • 21 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.